NASDAQ:ALDX

Aldeyra Therapeutics Stock Forecast

etoro logo Buy ALDX
*Your capital is at risk
$1.63
-0.130 (-7.39%)
At Close: Jun 05, 2026
AI Analysis AI Analysis of ALDX AI-Powered Market Insights
Stock Analysis PRO New!
Risk Assessment PRO New!
Trading Strategy PRO New!
Add ALDX to Watchlist?
  • Easy Tracking In The Watchlist
PDF

A very red day for Aldeyra Therapeutics stock price after a -7.39% fall in the Friday trading session
(Updated on Jun 05, 2026)

SIGN UP FREE
or
Creating an account or logging in means you agree to StockInvest.us Terms of Use and Privacy Policy.
Sell candidate since Jun 04, 2026 Loss -7.39%

The Aldeyra Therapeutics stock price fell by -7.39% on the last day (Friday, 5th Jun 2026) from $1.76 to $1.63. During the last trading day the stock fluctuated 8.98% from a day low at $1.62 to a day high of $1.76. The price has fallen in 6 of the last 10 days but is still up by 2.52% over the past 2 weeks. Volume fell on the last day along with the stock, which is actually a good sign as volume should follow the stock. On the last day, the trading volume fell by -127 thousand shares and in total, 946 thousand shares were bought and sold for approximately $1.54 million.

The stockhas broken the very wide and falling short-term trend up. Firstly a slower falling rate is indicated, but this may very well be an early signal of a trend shift. On the reaction, there will be support on the roof of the current trend broken, which is $1.49, a level that may pose a second chance to hit a runner. According to fan-theory $3.34 will be the next possible trend-top level and thereby pose a resistance level that may not be broken at the first attempt. Due to the high volatility and the trend direction we are not able to give forecast range for this stock. Do note, that if the stock price manages to stay at current levels or higher, our prediction target will start to change positively over the next few days as the conditions for the current predictions will be broken.

ALDX Signals & Forecast

Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Some negative signals were issued as well, and these may have some influence on the near short-term development. The Aldeyra Therapeutics stock holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the stock. On corrections up, there will be some resistance from the lines at $1.72 and $1.67. A break-up above any of these levels will issue buy signals. A sell signal was issued from a pivot top point on Monday, March 23, 2026, and so far it has fallen -26.91%. Further fall is indicated until a new bottom pivot has been found. Volume fell together with the price during the last trading day and this reduces the overall risk as volume should follow the price movements.

Support, Risk & Stop-loss for Aldeyra Therapeutics stock

Aldeyra Therapeutics finds support from accumulated volume at $1.59 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock has average movements during the day and with good trading volume, the risk is considered to be medium. During the last day, the stock moved $0.145 between high and low, or 8.98%. For the last week, the stock has had daily average volatility of 10.21%.

Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.

Trading Expectations (ALDX) For The Upcoming Trading Day Of Monday 8th

For the upcoming trading day on Monday, 8th we expect Aldeyra Therapeutics to open at $1.67, and during the day (based on 14 day Average True Range), to move between $1.56 and $1.70, which gives a possible trading interval of +/-$0.137 (+/-8.75%) up or down from last closing price. If Aldeyra Therapeutics takes out the full calculated possible swing range there will be an estimated 8.75% move between the lowest and the highest trading price during the day.

Since the stock is closer to the support from accumulated volume at $1.59 (2.45%) than the resistance at $1.68 (3.07%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..

Is Aldeyra Therapeutics stock A Buy?

Aldeyra Therapeutics holds several negative signals and is within a very wide and falling trend, so we believe it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock. Due to some small weaknesses in the technical picture we have downgraded our analysis conclusion for this stock since the last evaluation from a Sell to a Strong Sell candidate.

Current score: -6.217 Strong Sell Candidate Downgraded

Predicted Fair Opening Price

Predicted fair opening price on June 8, 2026 - $1.67 ( 2.35%).

Want to trade but not sure how? Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker* eToro
*Your capital is at risk

ALDX Performance

Trading levels for ALDX

StockInvest.us
Full Access. No Commitment. 7 Days Free!
Long & Short-Term Golden Star Lists
AI Stock Analysis*
Top 10 Candidates on Every List
Premium Lists
Ad-FREE Browsing
Advanced Stock Screener

Fibonacci Support & Resistance Levels

Level Price
R3 1.81 11.25%
R2 1.76 7.85%
R1 1.72 5.75%
Price 1.63
S1 1.61 -1.05%
S2 1.58 -3.15%
S3 1.52 -6.54%

Accumulated Volume Support & Resistance Levels

Level Price
R3 1.83 12.27%
R2 1.81 11.04%
R1 1.68 3.07%
Price 1.63
S1 1.59 -2.45%
S2 1.42 -12.88%
S3 1.24 -23.93%

FAQ

What is the symbol for Aldeyra Therapeutics Stock and on which exchange is it traded?
The symbol for Aldeyra Therapeutics is ALDX and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell Aldeyra Therapeutics Stock?
Aldeyra Therapeutics holds several negative signals and is within a very wide and falling trend, so we believe it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock. Due to some small weaknesses in the technical picture we have downgraded our analysis conclusion for this stock since the last evaluation from a Sell to a Strong Sell candidate.

How to buy Aldeyra Therapeutics Stock?
Aldeyra Therapeutics Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Aldeyra Therapeutics Stock.

What's the current price of Aldeyra Therapeutics Stock?
As of the end of day on the Jun 05, 2026, the price of an Aldeyra Therapeutics (ALDX) share was $1.63.

What is the 52-week high and low for Aldeyra Therapeutics Stock?
The 52-week high for Aldeyra Therapeutics Stock is $6.18 and the 52-week low is $1.07.

What is the market capitalization of Aldeyra Therapeutics Stock?
As of the Jun 05, 2026, the market capitalization of Aldeyra Therapeutics is 98.323M.

When is the next earnings date for Aldeyra Therapeutics?
The upcoming earnings date for Aldeyra Therapeutics is Aug 06, 2026.
Click to get the best stock tips daily for free!
ABOUT ALDEYRA THERAPEUTICS
Aldeyra Therapeutics
Aldeyra Therapeutics, Inc., a biotechnology company, develops and commercializes medicines for immune-mediated ocular and systemic diseases. The company's lead product candidate is reproxalap, a reactive aldehyde species (RASP)modulator, which is in Phase III clinical trial for the treatment of dry eye diseases and allergic conjunctivitis. It also develops ADX-629, a first-in-class orally administered RASP modulator that is Phase II clinical tria...
GOLDEN STAR
Ticker Change Signal Date
RUN
$12.83
4.09% May 06
GLBE
$31.61
1.65% May 05
SAP
$172.39
7.18% May 05
FIZZ
$34.11
7.04% May 01
ADBE
$243.57
3.23% Apr 29

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE